Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riboflavin in sports-related concussion
NCT02772237Phase 2Unknown
- Sponsor
- University of Virginia
- Start
- Aug 2016
- Primary completion
- Dec 2018
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of riboflavin in concussion (mTBI), sponsored by University of Virginia. Status: unknown.
02
Drugs
riboflavin
03
Conditions
concussion (mTBI)
Beyond the preview
Go deeper on NCT02772237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02772237.